No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
SG Stock MarketDetailed Quotes
1J5 Hyphens Pharma
- 0.280
- +0.005+1.82%
10min DelayTrading Jul 22 09:37 CST
86.58MMarket Cap10.00P/E (TTM)
0.280High0.280Low100Volume0.280Open0.275Pre Close28.00Turnover0.30052wk High0.00%Turnover Ratio309.20MShares0.19452wk Low0.028EPS TTM16.32MFloat Cap0.520Historical High7.57P/E (Static)58.29MShs Float0.040Historical Low0.037EPS LYR0.00%Amplitude0.01Dividend TTM1.26P/B100Lot Size3.93%Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Is Hyphens Pharma International Limited's (Catalist:1J5) Latest Stock Performance Being Led By Its Strong Fundamentals?
Singapore Shares Remain Flat Despite Overnight Gains in Global Markets; Zheneng Jinjiang Rises 3%
Singapore's Straits Times Index remained flat on Thursday despite overnight gains in the global markets led by technology stocks. During the day, the benchmark Singapore Strait Times Index ranged betw
Hyphens Pharma's Subsidiary Enters Exclusive Deal With Maruho
Hyphens Pharma (SGX:1J5) subsidiary, Hyphens Pharma Pte entered into an exclusive license, development and commercialization agreement with Maruho for the rights to register and commercialize Amenarel
Hyphens Pharma Subsidiary Enters Into Exclusive Licensing Agreement With Maruho for Shingles Medication
Hyphens Pharma Holds Insightful AGM
Hyphens Pharma International Reports First Quarter 2024 Earnings
Comments
declare 3.6 cents special dividend .... shareholders huat !
not bad div track record; hope profit will improve post-Covid environment ....
Hyphens Pharma Dividend Yield (1J5)
not bad div track record; hope profit will improve post-Covid environment ....
Hyphens Pharma Dividend Yield (1J5)
$Hyphens Pharma(1J5.SG$ "We're thrilled to be featured in SAC Capital Private Limited's video, as one of the investment gems ....."
Hyphens Pharma International Ltd. on LinkedIn: Uncovering Gems Listed on SGX series - Hyphens Pharma International…
Hyphens Pharma International Ltd. on LinkedIn: Uncovering Gems Listed on SGX series - Hyphens Pharma International…
1
$Hyphens Pharma(1J5.SG$
Phillip Capital Research Report 09 Mar 2023
Assembling multiple growth engines
Phillip Capital Research Report 09 Mar 2023
Assembling multiple growth engines
$Hyphens Pharma(1J5.SG$Hyphens Pharma reports two times surge in 2HFY2022 earnings of $5.2 mil ![]()
".... FY2022 earnings per share (EPS) stood at 3.66 cents on a diluted basis and on the group’s continuing operations. As at Dec 31, 2022, cash and cash equivalents stood at $36.5 million. A first and final dividend of 1.11 cents has been proposed for the period, up from FY2021’s dividend of 0.67 cents...."
".... FY2022 earnings per share (EPS) stood at 3.66 cents on a diluted basis and on the group’s continuing operations. As at Dec 31, 2022, cash and cash equivalents stood at $36.5 million. A first and final dividend of 1.11 cents has been proposed for the period, up from FY2021’s dividend of 0.67 cents...."
$Hyphens Pharma(1J5.SG$ watching 👀, trying to BO from 1 year pivot. Thinly traded counter though.
Read more
Analysis
Price Target
No Data
Heat List
SG
Overall
Symbol
Latest Price
%Chg